IBD serological markers (ASCA, pANCA, anti-OmpC, and anti-CBir1) were measured by ELISA in plasma from AIDS patients (n = 26) with low CD4 counts (<300 cells/μl) and high plasma LPS levels, and results correlated with clinical data. Here, CD4 is linked to inflammatory bowel disease.